Akduman, L. Et Al. 2010. Pegaptanib Versus Combined Pegaptanib and Photodynamic Therapy for Neovascular Age-Related Macular Degeneration. TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.30, no.3 , 978-984.

Akduman, L., Kaderli, B., Kim, M., Brusatti, R., & Jones, M., (2010). Pegaptanib Versus Combined Pegaptanib and Photodynamic Therapy for Neovascular Age-Related Macular Degeneration. TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.30, no.3, 978-984.

Akduman, Levent Et Al. "Pegaptanib Versus Combined Pegaptanib and Photodynamic Therapy for Neovascular Age-Related Macular Degeneration," TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.30, no.3, 978-984, 2010

Akduman, Levent Et Al. "Pegaptanib Versus Combined Pegaptanib and Photodynamic Therapy for Neovascular Age-Related Macular Degeneration." TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.30, no.3, pp.978-984, 2010

Akduman, L. Et Al. (2010) . "Pegaptanib Versus Combined Pegaptanib and Photodynamic Therapy for Neovascular Age-Related Macular Degeneration." TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.30, no.3, pp.978-984.

@article{article, author={Levent Akduman Et Al. }, title={Pegaptanib Versus Combined Pegaptanib and Photodynamic Therapy for Neovascular Age-Related Macular Degeneration}, journal={TURKIYE KLINIKLERI TIP BILIMLERI DERGISI}, year=2010, pages={978-984} }